Carlos Javier González Navarro

Research in bioactive, microbiota and probiotic compounds for prevention and treatment of the Metabolic syndrome, Carlos J. Gonzalez Navarro, University of Navarro. Metabolic syndrome is an asymptomatic physiopathological state associated with obesity that runs with insulin resistance, hypertension and dislipemia, and whose prevalence ranges from 20 to 25% in the adult population, increasing among older people. In addition, around 85% of patients with DM2 have metabolic syndrome.In the Nutrition Research Centre, various approaches are currently being reached for their prevention and treatment based on the use of bioactivos, probiotic compounds or microbiota evaluation and modulation through changes in food.